[On tryptophan metabolism and on nicotinic acid synthesis in Central Asiatic ergot].

D. Erge,D. Groeger,K. Mothes

Abstract:

What problem does this paper attempt to address?

Laparoscopic cholecystectomy in the presence of abdominal situs inversus: does surgeon positioning matter?

J. Simmons,E. Maxwell,Kenneth D. Vick

2009-04-01

The American Surgeon

Abstract:
Review Insights on Salivary Proteomics Biomarkers in Oral Cancer Detection and Diagnosis

Vidhya Rekha Umapathy,Prabhu Manickam Natarajan,Bhuminathan Swamikannu

DOI: https://doi.org/10.3390/molecules28135283

IF: 4.6

2023-07-07

Molecules

Abstract:Early detection is crucial for the treatment and prognosis of oral cancer, a potentially lethal condition. Tumor markers are abnormal biological byproducts produced by malignant cells that may be found and analyzed in a variety of bodily fluids, including saliva. Early detection and appropriate treatment can increase cure rates to 80–90% and considerably improve quality of life by reducing the need for costly, incapacitating medicines. Salivary diagnostics has drawn the interest of many researchers and has been proven to be an effective tool for both medication monitoring and the diagnosis of several systemic diseases. Since researchers are now searching for biomarkers in saliva, an accessible bodily fluid, for noninvasive diagnosis of oral cancer, measuring tumor markers in saliva is an interesting alternative to blood testing for early identification, post-treatment monitoring, and monitoring high-risk lesions. New molecular markers for oral cancer detection, treatment, and prognosis have been found as a result of developments in the fields of molecular biology and salivary proteomics. The numerous salivary tumor biomarkers and how they relate to oral cancer and pre-cancer are covered in this article. We are optimistic that salivary protein biomarkers may one day be discovered for the clinical detection of oral cancer because of the rapid advancement of proteomic technology.

chemistry, multidisciplinary,biochemistry & molecular biology
Capacitive and oxidant generating properties of black-colored TiO2 nanotube array fabricated by electrochemical self-doping.

Choonsoo Kim,Seonghwan Kim,Jaehan Lee,Jiye Kim,Jeyong Yoon

DOI: https://doi.org/10.1021/acsami.5b00123

2015-04-01

Abstract:Recently, black-colored TiO2 NTA (denoted as black TiO2 NTA) fabricated by self-doping of TiO2 NTA with the amorphous phase led to significant success as a visible-light-active photocatalyst. This enhanced photocatalytic activity is largely attributed to a higher charge carrier density as an effect of electrochemical self-doping resulting in a higher optical absorbance and lower transport resistance. Nevertheless, the potential of black TiO2 NTA for other electrochemical applications, such as a supercapacitor and an oxidant-generating anode, has not been fully investigated. Here, we report the capacitive and oxidant generating properties of black TiO2 NTA. The black TiO2 NTA exhibited significantly a high value for areal capacitance with a good rate capability and novel electrocatalytic activity in generating (•)OHs and Cl2 compared to pristine TiO2 NTA with the anatase phase. This study suggests that the black TiO2 NTA be applied as a supercapacitor and an oxidant generating anode.
The artificial endocrine pancreas in clinical research.

Pfeiffer Ef,W. Beishcher,W. Kerner

Abstract:
Salivary biomarkers for early detection of oral squamous cell carcinoma (OSCC) and head/neck squamous cell carcinoma (HNSCC): A systematic review and network meta-analysis

Shahnawaz Khijmatgar,Josh Yong,Nicole Rübsamen,Felice Lorusso,Pooja Rai,Niccolo Cenzato,Franscesca Gaffuri,Massimo Del Fabbro,Gianluca Martino Tartaglia

DOI: https://doi.org/10.1016/j.jdsr.2023.10.003

IF: 6.468

2023-12-22

Japanese Dental Science Review

Abstract:Oral cancer became a very common condition. WHO estimates that there are 4 cases of lip and oral cavity cancer for every 100,000 people worldwide. The early diagnosis of cancers is currently a top focus in the health sector. Recent systematic reviews and meta-analyses have identified promising biomarkers for early detection in several original research investigations. However, it is still unclear the quality of these evidence and which biomarker performs the best in terms of early detection. Therefore, the objective was, to map the methodological and reporting quality of available oral squamous cell carcinoma (OSCC) or head/neck squamous cell carcinoma (HNSCC) systematic reviews and meta-analysis. Secondly, to evaluate diagnostic accuracy of salivary biomarkers for common craniofacial cancers and to compare the diagnostic value of different salivary biomarkers. PubMed, Scopus, Web of Science, Embase and Cochrane Library electronic databases were used to map the methodological and reporting quality of the systematic reviews and meta-analysis conducted on the HNSCC, OSCC using the AMSTAR-2 checklist. The inclusion criteria were systematic reviews and meta-analysis published in the topic of HNSCC and OSCC biomarkers. Exclusion criteria were no animal studies; original primary studies, due to limitation of competency in other languages articles with language other than English were excluded. The sensitivity and specificity were calculated for salivary biomarkers and ranked according to network meta-analysis principles. A total of N = 5893 patients were included from four meta-analysis studies. All together, these included n = 37 primary studies. n = 94 biomarkers were pooled from these four meta-analyses and categorised into the stages at which they were detected (I-IV). In OSCC, Chemerin and MMP-9 displayed the highest sensitivity, registering 0.94 (95% CI 0.78, 1.00) and a balanced accuracy of 0.93. Phytosphingosine closely followed, with a sensitivity of 0.91 (95% CI 0.68, 0.99) and a balanced accuracy of 0.87. For HNSCC, the top three biomarkers are Actin, IL-1β Singleplex, and IL-8 ELISA. Actin leads with a sensitivity of 0.91 (95% CI 0.68–0.99), a specificity of 0.67, and an overall accuracy of 0.79. Subsequently, IL-1β Singleplex exhibits a sensitivity of 0.62 (95% CI 0.30–0.88), a specificity of 0.89, and an accuracy of 0.75, followed by IL-8 ELISA with a sensitivity of 0.81 (95% CI 0.54–0.97), a specificity of 0.59, and an accuracy of 0.70. In conclusion, there was highest sensitivity for MMP-9 and chemerin salivary biomarkers. There is need of further more studies to identify biomarkers for HNSCC and OSCC.

dentistry, oral surgery & medicine
Salivary Biomarkers for Oral Squamous Cell Carcinoma Diagnosis and Follow-Up: Current Status and Perspectives

Marta Cristaldi,Rodolfo Mauceri,Olga Di Fede,Giovanna Giuliana,Giuseppina Campisi,Vera Panzarella

DOI: https://doi.org/10.3389/fphys.2019.01476

IF: 4

2019-12-10

Frontiers in Physiology

Abstract:Oral cancer is the sixth most common cancer type in the world, and 90% of it is represented by oral squamous cell carcinoma (OSCC). Despite progress in preventive and therapeutic strategies, delay in OSCC diagnosis remains one of the major causes of high morbidity and mortality; indeed the majority of OSCC has been lately identified in the advanced clinical stage (i.e., III or IV). Moreover, after primary treatment, recurrences and/or metastases are found in more than half of the patients (80% of cases within the first 2 years) and the 5-year survival rate is still lower than 50%, resulting in a serious issue for public health. Currently, histological investigation represents the "gold standard" of OSCC diagnosis; however, recent studies have evaluated the potential use of non-invasive methods, such as "liquid biopsy," for the detection of diagnostic and prognostic biomarkers in body fluids of oral cancer patients. Saliva is a biofluid containing factors such as cytokines, DNA and RNA molecules, circulating and tissue-derived cells, and extracellular vesicles (EVs) that may be used as biomarkers; their analysis may give us useful information to do early diagnosis of OSCC and improve the prognosis. Therefore, the aim of this review is reporting the most recent data on saliva biomarker detection in saliva liquid biopsy from oral cancer patients, with particular attention to circulating tumor DNA (ctDNA), EVs, and microRNAs (miRNAs). Our results highlight that saliva liquid biopsy has several promising clinical uses in OSCC management; it is painless, accessible, and low cost and represents a very helpful source of diagnostic and prognostic biomarker detection. Even if standardized protocols for isolation, characterization, and evaluation are needed, recent data suggest that saliva may be successfully included in future clinical diagnostic processes, with a considerable impact on early treatment strategies and a favorable outcome.

physiology
Saliva-Based Biomarkers in Oral Squamous Cell Carcinoma Using OMICS Technologies: A Systematic Review

Fariba Esperouz,Domenico Ciavarella,Andrea Santarelli,Mauro Lorusso,Lorenzo Lo Muzio,Luigi Laino,Lucio Lo Russo

DOI: https://doi.org/10.3390/oral4030024

2024-07-02

Oral

Abstract:(1) Background: Head and neck cancer (HNC) is a major public health challenge worldwide, with oral squamous cell carcinoma (OSCC) being the predominant form. Despite advances in treatment, OSCC remains a major cause of morbidity and mortality due to delayed diagnosis and limited therapeutic efficacy. This study reviews omics technologies to assess new salivary biomarkers for the early detection of OSCC. (2) Methods: A comprehensive literature search in the last 20 years identified four relevant studies focusing on salivary biomarkers in OSCC. (3) Results: Proteomic and genomic analyses revealed significant changes in salivary composition between OSCC patients and healthy controls, suggesting promising diagnostic and prognostic biomarkers. However, studies showed varying degrees of bias, indicating the need for further research and improved standardization. (4) Conclusions: Saliva, with its advantages of ease of collection, minimal invasiveness, and potential for large-scale screening, is an emerging promising substrate for non-invasive biomarker research. Nonetheless, there is a need for improved biomarker sensitivity and specificity; currently, histological examination remains the golden standard.
Recent trends of saliva omics biomarkers for the diagnosis and treatment of oral cancer

Indranil Chattopadhyay,Madhusmita Panda

DOI: https://doi.org/10.1016/j.job.2019.03.002

2019-06-01

Journal of Oral Biosciences

Abstract:<h6>Background</h6><p>Recent advances in surgery, radiotherapy, and chemotherapy have no significant effect on oral cancer survival rates due to late diagnosis, poor tumor response to chemotherapy and radiotherapy, as well as a lack of effective biomarkers for early diagnosis.</p><h6>Highlights</h6><p>Therefore, an investigative study aimed at identifying genomics, proteomics, metagenomics, and, metabolomics derived biomarkers for early diagnosis may improve the survival rate of oral cancer patients. Identification and application of saliva-based ''omics'' biomarkers may overcome painful invasive procedures currently being used for the diagnosis of oral cancer. One single biomarker may not be able to differentiate between oral squamous cell carcinoma (OSCC) and controls. Thus, multiple sensitive and specific biomarkers may be needed for screening high-risk patients and following them up for early signs of OSCC occurrence. Validation of these biomarkers in large patient cohorts is, however, required before they can be used in clinical practice.</p><h6>Conclusion</h6><p>In this review, we summarize the potential of omics derived salivary biomarkers as diagnostic and prognostic tools in oral cancer detection and the future clinical benefits associated with these markers.</p><h5>Graphical abstract</h5>
Saliva as a Diagnostic Tool in Oral Squamous Cell Carcinoma – a Systematic Review with Meta Analysis

K. Hema Shree,Pratibha Ramani,Herald Sherlin,Gheena Sukumaran,Gifrrina Jeyaraj,K. R. Don,Archana Santhanam,Abilasha Ramasubramanian,R. Sundar

DOI: https://doi.org/10.1007/s12253-019-00588-2

2019-02-02

Abstract:Abstract Whole saliva is mainly composed of fluid produced by major and minor salivary glands. Major salivary glands including parotid, submandibular, and sublingual glands, are known to secrete fluid transported from serum as well as surrounding glandular tissues [1]. Beside the secretions from salivary glands, oral mucosa, periodontium, as well as oral microflora also contribute to the final content of whole saliva [1]. Whole saliva therefore represents a complex balance among local and systemic sources [2]. This allows for the application of saliva in the diagnosis not only for salivary gland disorders but also for oral diseases and systemic conditions [2]. The role of saliva as a diagnostic tool in detecting Oral Squamous Cell Carcinoma. Articles published in PUBMED, EMBASE, COCHRANE, GOOGLE, manual search and back references of the articles for last 5 years extracted 77 articles. Studies which considered saliva as a diagnostic tool were included. Statistical analysis with Receivers Operating Curve to establish sensitivity and specificity of the salivary biomarkers as a diagnostic tool to detect Oral Squamous Cell Carcinoma were included for meta analysis. The measure of effect with 95% confidence interval were meta analysed for 9 articles in which 308 healthy individuals compared with 340 patients with Oral Squamous Cell Carcinoma. Highly sensitive salivary biomarkers for detecting Oral Squamous Cell Carcinoma were MMP-9, Chemerin, Choline + Betaine + Pipecolinic Acid + I – Carnitine(confidence interval ranges from 0.83–1.0). The narrow confidence interval of 0.95 + (0.88–1.00) was seen for MMP-9 followed by 1.00 + (0.78–1.00) for chemerin. Highly specific biomarkers for Oral Squamous Cell Carcinoma were MMP-9 (specificity −100%,), Chemerin(specificity-100%), over expressed mi RNA 136 with specificity of 0.88(0.69–0.97), under expressed mi RNA 27B with specificity of 1.0(0.66–1.00). Saliva can be used as a diagnostic tool with highly sensitive and specific markers namely MMP-9, Chemerin for early detection of Oral Squamous Cell Carcinoma.

oncology,pathology
Salivary Metabolomics for Oral Cancer Detection: A Narrative Review

Karthika Panneerselvam,Shigeo Ishikawa,Rajkumar Krishnan,Masahiro Sugimoto

DOI: https://doi.org/10.3390/metabo12050436

IF: 4.1

2022-05-13

Metabolites

Abstract:The development of low- or non-invasive screening tests for cancer is crucial for early detection. Saliva is an ideal biofluid containing informative components for monitoring oral and systemic diseases. Metabolomics has frequently been used to identify and quantify numerous metabolites in saliva samples, serving as novel biomarkers associated with various conditions, including cancers. This review summarizes the recent applications of salivary metabolomics in biomarker discovery in oral cancers. We discussed the prevalence, epidemiologic characteristics, and risk factors of oral cancers, as well as the currently available screening programs, in India and Japan. These data imply that the development of biomarkers by itself is inadequate in cancer detection. The use of current diagnostic methods and new technologies is necessary for efficient salivary metabolomics analysis. We also discuss the gap between biomarker discovery and nationwide screening for the early detection of oral cancer and its prevention.

biochemistry & molecular biology
Salivaomics in head and neck cancer

Chandrarohini Saravanan,Rabiatul Basria S M N Mydin,Nur Rizikin Mohamed Sheriff,Gurjeet Kaur,Satvinder Singh Dhaliwal,Muhamad Yusri Musa

DOI: https://doi.org/10.1016/j.cca.2024.119952

2024-08-30

Abstract:Salivaomics is a promising method for the early detection and monitoring of head and neck cancer (HNC). By analyzing salivary proteomics, RNA, and DNA, it identifies biomarkers that distinguish HNC patients from healthy individuals. Saliva's non-invasive, easily collectible nature and affordability make it an advantageous screening tool. Multiomics approaches, which explore genetic mutations, gene expression patterns, protein profiles, and metabolite levels, provide a comprehensive molecular perspective that enhances clinical applicability. The approaches enhance the precision of diagnoses, enable the development and application of targeted therapies, and contribute to the overall advancement of personalized medicine. Despite its potential, larger-scale studies are essential for validating biomarkers, and assessing sensitivity, accuracy, and specificity in detecting HNC. This review highlights salivaomics' potential as a non-invasive, accessible biological sample for early disease detection in HNC and underscores the value of multiomics in advancing this research. Salivaomics offers significant insights into the underlying mechanisms of HNC, enabling the discovery of robust, non-invasive biomarkers for improved disease management.
An Exploratory Systematic Review

Daniel Bastías,Alejandro Maturana,Constanza Marín,René Martínez,Sven Eric Niklander

DOI: https://doi.org/10.3390/ijms25052634

IF: 5.6

2024-02-24

International Journal of Molecular Sciences

Abstract:Different efforts have been made to find better and less invasive methods for the diagnosis and prediction of oral cancer, such as the study of saliva as a source of biomarkers. The aim of this study was to perform a scoping review about salivary molecules that have been assessed as possible biomarkers for the diagnosis of oral squamous cell carcinoma (OSCC). A search was conducted using EBSCO, PubMed (MEDLINE), Scopus, and Web of Science. The research question was as follows: which molecules present in saliva have utility to be used as biomarkers for the early detection of oral cancer? Sixty-two studies were included. Over 100 molecules were assessed. Most of the markers were oriented towards the early diagnosis of OSCC and were classified based on their ability for detecting OSCC and oral potentially malignant disorders (OPMDs), OSCC outcome prediction, and the prediction of the malignant transformation of OPMDs. TNF-α, IL-1β, IL-6 IL-8, LDH, and MMP-9 were the most studied, with almost all studies reporting high sensitivity and specificity values. TNF-α, IL-1β, IL-6 IL-8, LDH, and MMP-9 are the most promising salivary biomarkers. However, more studies with larger cohorts are needed before translating the use of these biomarkers to clinical settings.

biochemistry & molecular biology,chemistry, multidisciplinary
A Review on Salivary Proteomics for Oral Cancer Screening

Qian Li,Xiangying Ouyang,Jiao Chen,Ping Zhang,Yun Feng

DOI: https://doi.org/10.21775/cimb.037.047

2020-01-01

Current Issues in Molecular Biology

Abstract:Oral cancer has emerged as a global health problem due to its relatively high incidence and mortality. Human saliva as a diagnostic fluid can offer an easy, inexpensive, safe and non-invasive approach for disease detection. Direct contact between saliva and oral cancer lesions make detection of salivary biomarkers for oral cancer especially attractive. Proteins are important molecules involved in pathological processes of oral cancer growth, apoptosis and metastasis. Proteins such as hormones, antibodies, enzymes and cytokines in saliva secreted by oral cancer cells or by host cells not only provide comprehensive pathological information of oral cancer but also are considered potential targets for non-invasive screening of oral cancer. This article provides a review of potential salivary proteomic biomarkers in oral cancer screening.

biochemistry & molecular biology
Current state of salivaomics and metabolomic profiling as novel diagnostics for biomarker research and applications in oral cancer and personalized medicine

Simi Thankappan,N Sherin

DOI: https://doi.org/10.4103/tjmr.tjmr_28_16

2017-01-01

Tropical Journal of Medical Research

Abstract:Biomarkers are the main focus of current researches in biological characteristics that are easily measured in patients, and their discovery has laid the foundation for personalized medicine. Salivaomics and metabolomics are the rapidly emerging diagnostics focused on comprehensive profiling of metabolites in intracellular or biofluid sample. A systematic search of PubMed Central, Ebsco Host, Science Direct, and Scopus was done and the search terms included salivaomics, metabolomics, biomarkers, metabolites, oral cancer, proteomics, personalized medicine, and omics. This review article summarizes on the significance of salivary metabolites as diagnostic and prognostic biomarkers due to different biochemical pathways in oral cancer patients and healthy controls, even early detection of cancer in patients, thus emphasizing on the rigorous need of future research in this field.
Salivary metabolomics in the diagnosis of oral cancer and periodontal diseases

J J W Mikkonen,S P Singh,M Herrala,R Lappalainen,S Myllymaa,A M Kullaa,J. J. W. Mikkonen,S. P. Singh,M. Herrala,R. Lappalainen,S. Myllymaa,A. M. Kullaa

DOI: https://doi.org/10.1111/jre.12327

2015-10-08

Journal of Periodontal Research

Abstract:Metabolomics is a systemic study of metabolites, which are small molecules generated by the process of metabolism. The metabolic profile of saliva can provide an early outlook of the changes associated with a wide range of diseases, including oral cancer and periodontal diseases. It is possible to measure levels of disease-specific metabolites using different methods as presented in this study. However, many challenges exist including incomplete understanding of the complicated metabolic pathways of different oral diseases. The review concludes with the discussion on future perspectives of salivary metabolomics from a clinician point of view. Salivary metabolomics may afford a new research avenue to identify local and systemic disorders but also to aid in the design and modification of therapies. A MEDLINE search using keywords "salivary metabolomics" returned 23 results in total, of which seven were omitted for being reviews or letters to the editor. The rest of the articles were used for preparation of the review, 13 of these were published in the last 5 years.

dentistry, oral surgery & medicine
Salivary Biomarkers for Detection of Oral Squamous Cell Carcinoma: Current State and Recent Advances

Maha Yakob,Laurel Fuentes,Marilene B. Wang,Elliot Abemayor,David T.W. Wong

DOI: https://doi.org/10.1007/s40496-014-0014-y

2014-03-21

Current Oral Health Reports

Abstract:Oral squamous cell carcinoma (OSCC) is the most common malignant neoplasm of the oral cavity. Detection of OSCC is currently based on a thorough clinical oral examination combined with a biopsy for histological analysis. Most cases of OSCC are not detected until the cancer has developed into advanced stages; thus, a reliable early-stage diagnostic marker is needed. This literature review presents an overview of the status of current advances in salivary diagnostics for OSCC. Though many protein and mRNA salivary biomarkers have been identified that can detect OSCC with high sensitivity and specificity, the most discernable findings occur with the use of multiple markers. Studies that incorporate proteomic, transcriptomic, and potentially additional “omics”, including methylomics, need to be initiated to bring technology to clinical applications and allow the best use of saliva in diagnosing OSCC.
Emerging technologies for salivaomics in cancer detection.

Karolina Elżbieta Kaczor-Urbanowicz,Carmen Martín Carreras-Presas,Tadeusz Kaczor,Michael Tu,Fang Wei,Franklin Garcia-Godoy,David T. Wong

DOI: https://doi.org/10.1111/jcmm.13007

2017-01-01

Journal of Cellular and Molecular Medicine

Abstract:Salivary diagnostics has great potential to be used in the early detection and prevention of many cancerous diseases. If implemented with rigour and efficiency, it can result in improving patient survival times and achieving earlier diagnosis of disease. Recently, extraordinary efforts have been taken to develop non-invasive technologies that can be applied without complicated and expensive procedures. Saliva is a biofluid that has demonstrated excellent properties and can be used as a diagnostic fluid, since many of the biomarkers suggested for cancers can also be found in whole saliva, apart from blood or other body fluids. The currently accepted gold standard methods for biomarker development include chromatography, mass spectometry, gel electrophoresis, microarrays and polymerase chain reaction-based quantification. However, salivary diagnostics is a flourishing field with the rapid development of novel technologies associated with point-of-care diagnostics, RNA sequencing, electrochemical detection and liquid biopsy. Those technologies will help introduce population-based screening programs, thus enabling early detection, prognosis assessment and disease monitoring. The purpose of this review is to give a comprehensive update on the emerging diagnostic technologies and tools for the early detection of cancerous diseases based on saliva.
Emerging Technologies for Salivaomics in Cancer Detection

Karolina Elżbieta Kaczor‐Urbanowicz,Carmen Martín Carreras‐Presas,Tadeusz Kaczor,Manghui Tu,Wei Fang,Franklin García‐Godoy,David T. Wong

DOI: https://doi.org/10.1111/jcmm.13007

2016-01-01

Journal of Cellular and Molecular Medicine

Abstract:Salivary diagnostics has great potential to be used in the early detection and prevention of many cancerous diseases. If implemented with rigour and efficiency, it can result in improving patient survival times and achieving earlier diagnosis of disease. Recently, extraordinary efforts have been taken to develop non‐invasive technologies that can be applied without complicated and expensive procedures. Saliva is a biofluid that has demonstrated excellent properties and can be used as a diagnostic fluid, since many of the biomarkers suggested for cancers can also be found in whole saliva, apart from blood or other body fluids. The currently accepted gold standard methods for biomarker development include chromatography, mass spectometry, gel electrophoresis, microarrays and polymerase chain reaction‐based quantification. However, salivary diagnostics is a flourishing field with the rapid development of novel technologies associated with point‐of‐care diagnostics, RNA sequencing, electrochemical detection and liquid biopsy. Those technologies will help introduce population‐based screening programs, thus enabling early detection, prognosis assessment and disease monitoring. The purpose of this review is to give a comprehensive update on the emerging diagnostic technologies and tools for the early detection of cancerous diseases based on saliva.
Salivary metabolomics – A diagnostic and biologic signature for oral cancer

Deepa Jatti Patil,Chandramani B. More

DOI: https://doi.org/10.1016/j.ajoms.2021.02.003

2021-09-01

Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology

Abstract:<p>Early detection of Oral Cancer (OC) with non-invasive tools and screening of high-risk populations remains to be an unmet need. Metabolic reprogramming is an important hallmark of cancer. This review discusses the role of Salivary metabolomics (SM) in the diagnosis of OC and precancer. An electronic search was carried out in various databases with keywords "Salivary Metabolomics" "Oral Cancer" "Oral leukoplakia" and "Oral Lichen planus" from 2005 to July 2020. A total number of 48 studies were included out of which 38 were excluded. Several characteristic salivary metabolites were significantly altered in OC and precancer patients. SM techniques can be used to explore the metabolic signatures in OC and precancer, unravel its pathogenesis and develop targeted therapies.</p>

[On tryptophan metabolism and on nicotinic acid synthesis in Central Asiatic ergot].

Laparoscopic cholecystectomy in the presence of abdominal situs inversus: does surgeon positioning matter?

Review Insights on Salivary Proteomics Biomarkers in Oral Cancer Detection and Diagnosis

Capacitive and oxidant generating properties of black-colored TiO2 nanotube array fabricated by electrochemical self-doping.

The artificial endocrine pancreas in clinical research.

Salivary biomarkers for early detection of oral squamous cell carcinoma (OSCC) and head/neck squamous cell carcinoma (HNSCC): A systematic review and network meta-analysis

Salivary Biomarkers for Oral Squamous Cell Carcinoma Diagnosis and Follow-Up: Current Status and Perspectives

Saliva-Based Biomarkers in Oral Squamous Cell Carcinoma Using OMICS Technologies: A Systematic Review

Recent trends of saliva omics biomarkers for the diagnosis and treatment of oral cancer

Saliva as a Diagnostic Tool in Oral Squamous Cell Carcinoma – a Systematic Review with Meta Analysis

Salivary Metabolomics for Oral Cancer Detection: A Narrative Review

Salivaomics in head and neck cancer

An Exploratory Systematic Review

A Review on Salivary Proteomics for Oral Cancer Screening

Current state of salivaomics and metabolomic profiling as novel diagnostics for biomarker research and applications in oral cancer and personalized medicine

Salivary metabolomics in the diagnosis of oral cancer and periodontal diseases

Salivary Biomarkers for Detection of Oral Squamous Cell Carcinoma: Current State and Recent Advances

Emerging technologies for salivaomics in cancer detection.

Emerging Technologies for Salivaomics in Cancer Detection

Salivary metabolomics – A diagnostic and biologic signature for oral cancer